High-risk HPV-DNA
Comparison of the Third Wave Invader Human Papillomavirus (HPV) Assay and the Digene HPV Hybrid Capture 2 Assay for Detection of High Risk HPV DNA
6
Absence of high risk HPV 16 and 18 in Chinese patients with oral squamous cell carcinoma and oral potentially malignant disorders
9
Transmission of High Risk Human Papillomavirus (HPV) between Parents and Infant: a Prospective Study of HPV in Families in Finland
6
Development and Characterization of the cobas Human Papillomavirus Test
8
Human Papilloma Virus (HPV) in squamous cell carcinoma of the oesophagus
95
Performance of the Aptima High Risk Human Papillomavirus mRNA Assay in a Referral Population in Comparison with Hybrid Capture 2 and Cytology
6
Low and High Risk Human Papillomavirus in the Oral Mucosa of Mexican Women with Genital Papillomavirus
8
Characteristics of human papillomaviruses infection in men with genital warts in Shanghai
8
Clinical validation of the HPVIR high risk HPV test on cervical samples according to the international guidelines for human papillomavirus DNA test requirements for cervical cancer screening
7
Accuracy and interlaboratory reliability of human papillomavirus DNA testing by hybrid capture
6
High Risk Human Papillomavirus (hrHPV) E6/E7 mRNA Testing by PreTect HPV Proofer for Detection of Cervical High Grade Intraepithelial Neoplasia and Cancer among hrHPV DNA Positive Women with Normal Cytology
7
Human Papillomavirus (HPV) DNA Copy Number Is Dependent on Grade of Cervical Disease and HPV Type
5
Human papillomavirus-mediated carcinogenesis and HPV-associated oral and oropharyngeal squamous cell carcinoma. Part 2: Human papillomavirus associated oral and oropharyngeal squamous cell carcinoma
6
Performance of Human Papillomavirus DNA and mRNA Testing Strategies for Women with and without Cervical Neoplasia
7
Association between human papillomavirus DNA and temporal arteritis
9
Comparison of the Abbott RealTime High Risk Human Papillomavirus (HPV), Roche Cobas HPV, and Hybrid Capture 2 Assays to Direct Sequencing and Genotyping of HPV DNA
7
A cross sectional study on the concordance between vaginal HPV DNA detection and type specific antibodies in a multi ethnic cohort of women from Amsterdam, the Netherlands – the HELIUS study
10
Human papilloma virus E6/E7 messenger RNA as a biomarker for detecting the risk evaluation of cervical cancer progression: overview of recent clinical trials
11
GP5+/6+ PCR followed by Reverse Line Blot Analysis Enables Rapid and High Throughput Identification of Human Papillomavirus Genotypes
9
Results: The overall prevalence of HPV was 18.01%. The high-risk
23